<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00616486</url>
  </required_header>
  <id_info>
    <org_study_id>psiy-266-07</org_study_id>
    <nct_id>NCT00616486</nct_id>
  </id_info>
  <brief_title>rTMS in Treatment of Obsessive Compulsive Disorder (OCD)</brief_title>
  <official_title>A Multicentre, Double-blind, Randomized, Placebo-controlled Study Evaluating the Efficacy, Safety, and Clinical Outcomes of Low Frequency, Repetitive Transcranial Magnetic Stimulation (Over Supplementary Motor Area (SMA) Applied Bilaterally and Simultaneously) Versus Sham (Placebo rTMS) Treatment for 6 Weeks, When Added to a Stable Pharmacotherapy in Subjects With Obsessive Compulsive Disorder (OCD).</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Queen's University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Military Medical Academy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dokuz Eylul University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Queen's University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Low frequency (1Hz) rTMS applied bilaterally and simultaneously over SMA for 6 weeks in
      addition to the standard treatment regimen for OCD, will lead to significant improvement in
      patients' symptoms. The clinical improvement detected by YBOCS, CGI and SF-36 QOLS scores
      will be statistically significant in active treatment group compared to sham (placebo)
      treatment group.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">November 2012</completion_date>
  <primary_completion_date type="Actual">May 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Yale-Brown Obsessive Compulsive Scale (YBOCS)</measure>
    <time_frame>pre, week 1, 2, 4, 6, 8, 12</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical Global Impression</measure>
    <time_frame>pre, week 1, 2, 4, 6, 8, 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hamilton Depression Rating Scale-21(HDRS)</measure>
    <time_frame>pre, week 1, 2, 4, 6, 8, 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pittsburgh Sleep Quality Index (PSQI)</measure>
    <time_frame>pre, week 1, 2, 4, 6, 8, 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hamilton Anxiety Rating Scale (HARS)</measure>
    <time_frame>pre, week 1, 2, 4, 6, 8, 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF-36 QOLS version (1)</measure>
    <time_frame>pre, week 1, 2, 4, 6, 8, 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analogue Scale</measure>
    <time_frame>pre, week 1, 2, 4, 6, 8, 12</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Obsessive Compulsive Disorder</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>repetitive transcranial magnetic stimulation</intervention_name>
    <description>6 weeks of stimulation with RMT frequency 1Hz, intensity 110% of RMT for 20 minutes, 5 minutes of trains with 2 minutes of intra-train intervals to both SMA. Treatment will be given 5 times a week for 4 weeks, 3 times a week during Week 5 and 2 times a week during Week 6.</description>
    <arm_group_label>1</arm_group_label>
    <other_name>rTMS machine (MagPro, Medtronic)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sham (placebo)</intervention_name>
    <description>Sham treatment will mimic active treatment mentioned above.</description>
    <arm_group_label>2</arm_group_label>
    <other_name>rTMS machine (MagPro, Medtronic).</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  signed patient informed consent;

          -  primary obsessive compulsive disorder;

          -  YBOCS score at least 20;

          -  males/females 18-65yrs;

          -  treated with adequate dose of SSRI at least 8 weeks at some stage of illness;

          -  currently using adequate, stable dose of SSRI at least 4 weeks but not responding.

        Exclusion Criteria:

          -  schizophrenia, other psychotic disorders, bipolar I, current major depressive disorder
             (HDRS(17)&gt;18, substance/alcohol dependence within last 6 months;

          -  severe axis II;

          -  suicidal score&gt;=6 on MINI;

          -  metallic implant in cranium;

          -  severe/unstable medical conditions;

          -  not responding to ECT or had TMS in last 6 months;

          -  history epilepsy;

          -  neurological disorder leading to increased intracranial pressure;

          -  severe cardiac disorder/intracardiac lines, pacemakers;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roumen Milev, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Queen's University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Military Medical Academy</name>
      <address>
        <city>Sofia</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Providence Care, Mental Health Services</name>
      <address>
        <city>Kingston</city>
        <state>Ontario</state>
        <zip>K7L 4X3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dokuz Eylul University</name>
      <address>
        <city>Izmir</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Bulgaria</country>
    <country>Canada</country>
    <country>Turkey</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 4, 2008</study_first_submitted>
  <study_first_submitted_qc>February 4, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 15, 2008</study_first_posted>
  <last_update_submitted>December 14, 2015</last_update_submitted>
  <last_update_submitted_qc>December 14, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 16, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Queen's University</investigator_affiliation>
    <investigator_full_name>Dr. Roumen Milev</investigator_full_name>
    <investigator_title>Professor of Psychiatry and Psychology, Head, Department of Psychiatry Queen's University</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Compulsive Personality Disorder</mesh_term>
    <mesh_term>Obsessive-Compulsive Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

